STEPHANIE DEVAULT: Open Payments
NPI 1265848535 · MASSILLON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 33 payments from 9 companies in 2025. Trend: 2023 $504 · 2024 $694 · 2025 $412
Food & beverage: $395Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $169 |
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Insmed, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| HARMONY BIOSCIENCES LLC | 2 | $31 |
| Viatris Specialty LLC | 1 | $23 |
| Pulmonx Corporation | 1 | $18 |
| Amgen Inc. | 1 | $18 |
Products named: NUCALA, TRELEGY ELLIPTA, INGREZZA, DUPIXENT, WAKIX, YUPELRI, CHARTIS CATHETER, TEZSPIRE.
Industry payments across OH — which companies pay providers there.
